Viral-Vector Vaccine Manufacturing - BioProcess International
Viral vector vaccines receive far less attention, but they merit serious consideration because they hold much promise for mitigating infectious diseases.
Stay updated with breaking news from Stefano Colloca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Viral vector vaccines receive far less attention, but they merit serious consideration because they hold much promise for mitigating infectious diseases.
AIFA has granted operational authorisation to ReiThera to open its new production area at its pharmaceutical facility at the Castel Romano Technopole.
/PRNewswire/ -- ReiThera, a biotech company dedicated to the development of new technologies, GMP production and the clinical translation of genetic vaccines...
- New 1,500 sq.m. facility granted operational authorisation from AIFA, the Italian Medicines Agency, to enable production scales of up to 3,000 liters; - New facility will allow ReiThera
/PRNewswire/ -- ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and...